A novel graph-based AI system, RSA-KG, significantly improves clinical decision support for diagnosing recurrent spontaneous abortion (RSA) by integrating multimodal clinical data and expert guidelines.
Key Details
- 1RSA-KG integrates structured and unstructured clinical data, including imaging reports, lab values, and molecular biomarkers.
- 2The knowledge graph is built from five major international RSA guidelines and extensive literature using NLP and multimodal AI models.
- 3A rigorous evaluation with 3,000 clinician-validated questions showed RSA-KG-enhanced LLMs outperform naive RAG and raw models (e.g., 86.5% vs. 76.5% accuracy for DeepSeek-R1).
- 4Qualitative expert scoring from 10 clinicians confirmed higher clinical usefulness of RSA-KG outputs over standard LLMs and other medical models.
- 5Key limitations include limited biomarker recency, single-discipline expert evaluation, and need for multicenter clinical validation.
Why It Matters
RSA-KG demonstrates a state-of-the-art integration of guidelines, imaging, and clinical data via AI, highlighting pathways to more adaptable and clinically relevant decision support systems in complex diagnostic areas. Radiology-AI professionals can leverage such frameworks for robust, multimodal reasoning and model validation.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.